ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 234 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,368,044 | -5.2% | 1,321,769 | -9.1% | 0.00% | 0.0% |
Q2 2023 | $18,311,630 | -52.5% | 1,453,304 | -50.8% | 0.00% | -50.0% |
Q1 2023 | $38,519,215 | -3.5% | 2,951,664 | +30.5% | 0.00% | -20.0% |
Q4 2022 | $39,913,640 | -4.0% | 2,262,678 | -17.1% | 0.01% | 0.0% |
Q3 2022 | $41,588,000 | +4.3% | 2,730,662 | +1.5% | 0.01% | 0.0% |
Q2 2022 | $39,890,000 | -21.6% | 2,689,806 | +19.1% | 0.01% | 0.0% |
Q1 2022 | $50,866,000 | -2.9% | 2,258,643 | -20.5% | 0.01% | 0.0% |
Q4 2021 | $52,393,000 | +166.2% | 2,839,736 | +92.9% | 0.01% | +150.0% |
Q3 2021 | $19,684,000 | -16.2% | 1,472,264 | +16.0% | 0.00% | 0.0% |
Q2 2021 | $23,490,000 | +9.9% | 1,269,084 | -10.8% | 0.00% | 0.0% |
Q1 2021 | $21,371,000 | +33.1% | 1,423,310 | +28.0% | 0.00% | 0.0% |
Q4 2020 | $16,055,000 | +51.5% | 1,111,799 | -14.6% | 0.00% | +100.0% |
Q3 2020 | $10,597,000 | +2.8% | 1,301,810 | -14.5% | 0.00% | -50.0% |
Q2 2020 | $10,310,000 | +6.2% | 1,522,907 | +10.4% | 0.00% | 0.0% |
Q1 2020 | $9,710,000 | -11.0% | 1,379,314 | +24.0% | 0.00% | +100.0% |
Q4 2019 | $10,915,000 | -30.1% | 1,112,017 | -21.8% | 0.00% | -50.0% |
Q3 2019 | $15,614,000 | +26.8% | 1,421,949 | +34.3% | 0.00% | 0.0% |
Q2 2019 | $12,310,000 | +41.3% | 1,058,506 | +16.0% | 0.00% | +100.0% |
Q1 2019 | $8,709,000 | -46.6% | 912,822 | -46.0% | 0.00% | -66.7% |
Q4 2018 | $16,303,000 | +39.7% | 1,691,091 | +106.5% | 0.00% | +50.0% |
Q3 2018 | $11,668,000 | +41.7% | 818,812 | +19.3% | 0.00% | +100.0% |
Q2 2018 | $8,237,000 | -19.6% | 686,370 | -17.2% | 0.00% | -50.0% |
Q1 2018 | $10,240,000 | -2.2% | 829,243 | +15.3% | 0.00% | 0.0% |
Q4 2017 | $10,468,000 | -43.3% | 719,438 | -44.5% | 0.00% | -33.3% |
Q3 2017 | $18,446,000 | +6.2% | 1,296,243 | -4.8% | 0.00% | 0.0% |
Q2 2017 | $17,364,000 | +45.2% | 1,360,920 | +44.3% | 0.00% | +50.0% |
Q1 2017 | $11,960,000 | +69.7% | 943,204 | +36.6% | 0.00% | 0.0% |
Q4 2016 | $7,049,000 | -28.5% | 690,396 | -7.8% | 0.00% | 0.0% |
Q3 2016 | $9,864,000 | -17.2% | 748,935 | -20.2% | 0.00% | -33.3% |
Q2 2016 | $11,912,000 | -2.8% | 937,968 | +1.1% | 0.00% | 0.0% |
Q1 2016 | $12,250,000 | +0.0% | 927,378 | +16.4% | 0.00% | 0.0% |
Q4 2015 | $12,249,000 | +32.3% | 796,411 | +6.7% | 0.00% | +50.0% |
Q3 2015 | $9,256,000 | +458.9% | 746,428 | +516.6% | 0.00% | +100.0% |
Q2 2015 | $1,656,000 | +391.4% | 121,052 | +329.8% | 0.00% | – |
Q1 2015 | $337,000 | +501.8% | 28,166 | +551.5% | 0.00% | – |
Q4 2014 | $56,000 | -94.3% | 4,323 | -94.1% | 0.00% | – |
Q3 2014 | $975,000 | -25.9% | 72,691 | -11.2% | 0.00% | – |
Q2 2014 | $1,315,000 | -10.5% | 81,901 | +0.5% | 0.00% | -100.0% |
Q1 2014 | $1,469,000 | -15.4% | 81,521 | -27.4% | 0.00% | 0.0% |
Q4 2013 | $1,736,000 | +34.7% | 112,300 | +29.6% | 0.00% | 0.0% |
Q3 2013 | $1,289,000 | +27.1% | 86,656 | +10.6% | 0.00% | – |
Q2 2013 | $1,014,000 | – | 78,345 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kent Lake Capital LLC | 925,000 | $12,154,500 | 4.67% |
EVR Research LP | 1,289,037 | $16,937,946 | 4.48% |
Tamarack Advisers, LP | 435,000 | $5,715,900 | 3.70% |
KESTREL INVESTMENT MANAGEMENT CORP | 263,900 | $3,468 | 2.19% |
Tamarack Advisers, LP | 200,000 | $2,628,000 | 1.70% |
Numerai GP LLC | 274,319 | $3,604,552 | 1.20% |
Smith, Graham & Co., Investment Advisors, LP | 525,915 | $6,910,523 | 0.86% |
PEREGRINE CAPITAL MANAGEMENT LLC | 585,254 | $7,690,238 | 0.23% |
WESTFIELD CAPITAL MANAGEMENT CO LP | 2,401,754 | $31,559,048 | 0.22% |
FULLER & THALER ASSET MANAGEMENT, INC. | 2,543,242 | $33,418,194 | 0.19% |